BioCentury | Sep 26, 2019
Financial News

ZielBio raises $25M series A to advance two new cancer targets

ZielBio raised a $25 million series A round from Morningside and Partners Innovation Fund to advance a functional proteomics platform that has generated two first-in-class preclinical mAbs targeting CSP1 and HRNR. The company was founded...
BioCentury | Apr 23, 2019
Company News

Pilot program for GSK's malaria vaccine starts in Malawi

...a fourth dose at about two years. RTS,S is a vaccine targeting the circumsporozoite protein (CSP...
BioCentury | Jan 11, 2019
Clinical News

CereSpir's itanapraced reduces neurotoxicity in PD model

...CereSpir Inc. (New York, N.Y.) reported on Dec. 10 that lead product itanapraced (CSP-1103) reduced neurotoxicity...
...Italy Product: Itanapraced (CSP-1103) Business: Neurology Indication: Treat Parkinson’s disease Hongjiang Li CereSpir Inc. Chiesi Farmaceutici S.p.A. Parkinson's disease (PD) CSP-1103 Itanapraced...
BioCentury | Oct 27, 2017
Clinical News

GSK begins Phase II of malaria vaccine candidate

...27, 2015 & May 4, 2017 ). Mosquirix is a vaccine targeting the circumsporozoite protein (CSP...
...Product: RTS,S vaccine (Mosquirix, GSK257049) Business: Infectious Molecular target: Plasmodium circumsporozoite protein (CSP) Description: Malaria vaccine targeting the CSP...
...and safety Status: Phase II started Milestone: NA Chris Lieu GSK257049 Mosquirix RTS,S vaccine GlaxoSmithKline plc Walter Reed Army Institute of Research Plasmodium circumsporozoite protein (CSP)...
BioCentury | Apr 6, 2017
Distillery Techniques

Biomarkers

...Blood levels of immune cell markers and antibodies could help predict protective responses to Plasmodium CSP...
...RTS,S vaccine , the absence of detectable parasitemia was associated with high pre-challenge titers of CSP-specific...
...third dose. In 21 volunteers receiving a priming dose of an adenoviral vaccine encoding parasitic CSP...
BioCentury | Jan 12, 2017
Company News

GeneCentric, Bristol-Myers Squibb deal

...Bristol-Myers Squibb and GeneCentric partnered to explore the feasibility of using GeneCentric’s Cancer Subtype Platform (CSP...
BioCentury | Jan 6, 2017
Clinical News

GAP3KO vaccine: Ph I data

...p36 and sap1 genes deleted Indication: Vaccinate against malaria infection Endpoint: Safety; circumsporozoite protein (CSP...
BioCentury | Oct 19, 2015
Company News

Oberland Capital Management LLC, Agenus deal

...right to buy back the note, which bears 13.5% interest. RTS,S targets the circumsporozoite protein (CSP...
BioCentury | Jul 27, 2015
Clinical News

RTS regulatory update

...caused by Plasmodium falciparum and against hepatitis B. The malaria vaccine targeting the circumsporozoite protein (CSP...
BioCentury | Jul 25, 2015
Company News

CHMP backs GSK's malaria vaccine

...for marketing authorization in countries in sub-Saharan Africa. Mosquirix (RTS, S) targets the circumsporozoite protein (CSP...
Items per page:
1 - 10 of 42